[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359112-105":59,"doc-detail-359112-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","lactate-metabolism-immune-regulation-related-gene-signature-in-lower-grade-gliomas-prognostic-model-development-and-immune-characterization","Lactate Metabolism-Immune Regulation-Related Gene Signature in Lower-Grade Gliomas - Prognostic Model Development and Immune Characterization","","Low-grade gliomas represent a diverse group of central nervous system tumors with heterogeneous outcomes. Metabolic reprogramming, especially lactate metabolism, relates to the tumor immune microenvironment, yet the prognostic relevance of associated genes in LGG remains unclear. Using TCGA and CGGA cohorts, the study performed consensus clustering on lactate metabolism genes and built a differential-analysis Cox-LASSO predictive model. The three-gene signature (VAV3, TNFRSF12A, PLA2G2A) separated high- and low-risk patients, linked with immune infiltration, TMB, and therapy responsiveness. Functional validation supported PLA2G2A as a driver of proliferation, migration, invasion, and in vivo growth, and implicated EMT reversal.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lactate-metabolism-immune-regulation-related-gene-signature-in-lower-grade-gliomas-prognostic-model-development-and-immune-characterization/359112/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lactate-metabolism-immune-regulation-related-gene-signature-in-lower-grade-gliomas-prognostic-model-development-and-immune-characterization/359112.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What cohorts and methods were used to construct the prognostic model for LGG?","Question",{"text":113,"@type":114},"The study used TCGA and CGGA cohorts, applying consensus clustering based on lactate metabolism genes. A predictive model was built using differential analysis, Cox regression, and LASSO.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the three-gene signature relate to patient risk and immune features?",{"text":118,"@type":114},"The signature (VAV3, TNFRSF12A, PLA2G2A) distinguishes high-risk from low-risk patients with high predictive accuracy. High-risk patients show reduced immune infiltration and increased TMB, corresponding to worse prognosis.",{"name":120,"@type":111,"acceptedAnswer":121},"How was the key gene PLA2G2A functionally validated?",{"text":122,"@type":114},"PLA2G2A expression and impact were assessed with RT-qPCR, Western blot, immunofluorescence, ELISA, CCK-8, Transwell assays, and mouse tumorigenesis experiments, showing that downregulation suppresses tumor progression and reverses EMT.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},359112,1790516151,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","The FASEB Journal  \nRESEARCH ARTICLE  OPEN ACCESS   \nLactate Metabolism-Immune Regulation-Related Gene Signature in Lower-Grade Gliomas: Prognostic Model Development and Immune Characterization  \nEnhao Zhang  | Liangzhe Wei | He Ren | Jianfei Zhang | Hongqiao Yang | Meng Sun | Xiang Gao | Yi Huang   \nNingbo Key Laboratory of Nervous System and Brain Function, Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China  \nCorrespondence: Xiang Gao ([fyygaoxiang@nbu.edu.cn](fyygaoxiang@nbu.edu.cn)) | Yi Huang ([huangy102@gmail.com](huangy102@gmail.com))  \nReceived: 12 October 2025 | Revised: 6 February 2026 | Accepted: 19 February 2026  \nKeywords: immune microenvironment | lactate metabolism-immune regulation-related genes | low-grade glioma | PLA2G2A | prognostic model | tumor mutation burden  \nABSTRACT  \nLow-grade gliomas represent a diverse category of central nervous system tumors, characterized by considerable variability in prognosis. Metabolic reprogramming, particularly lactate metabolism, has been associated with the tumor immune microenvironment; however, the prognostic significance of the related genes in LGG is still not well understood. This study used TCGA and CGGA cohorts to perform consensus clustering based on genes involved in lactate metabolism. A predictive model was constructed using differential analysis, Cox regression, and LASSO methods. The model's association with immune cell infiltration, TMB, and drug responsiveness was also evaluated. The function of the key gene PLA2G2A was validated using RT-qPCR, Western blot, immunofluorescence, ELISA, CCK-8, Transwell assays, and mouse tumorigenesis experiments. Consensus clustering classified LGG into two distinct subtypes, each showing significant variations in survival and immune profiles. The three-gene signature (VAV3, TNFRSF12A, PLA2G2A) effectively distinguished high-risk from low-risk patients, demonstrating high predictive accuracy in both TCGA and CGGA datasets. Patients categorized as high-risk showed reduced immune infiltration, increased TMB, and a worse prognosis. Additionally, they showed increased sensitivity to tyrosine kinase inhibitors and platinum-based therapies. Functional experiments showed that PLA2G2A was highly expressed in gliomas, and its downregulation notably reduced tumor cell proliferation, migration, invasion, and growth in vivo, while reversing the epithelial-mesenchymal transition. This study proposes and validates a novel three-gene prognostic model that reflects the metabolic-immune interactions in LGG, predicts patient prognosis, and suggests potential therapeutic targets. The functional validation of PLA2G2A further underscores its potential as a therapeutic biomarker.  \n1 | Introduction  \nLow-grade glioma (LGG) is a frequently occurring, diffuse tumor within the central nervous system, encompassing WHO grades II-III astrocytomas, oligodendrogliomas, and oligoastrocytomas [1] . LGG typically occurs in young adults and often presents with seizures as the first symptom. Although it grows more slowly than high-grade gliomas, it is prone to recurrence  \nand eventually progresses to glioblastoma (GBM), leading to a poor prognosis [2, 3] . Current treatment mainly involves surgical resection, supplemented by radiotherapy and chemotherapy (e.g., temozolomide) . However, due to its heterogeneity and recurrence, the therapeutic efficacy remains limited [4] . Determining novel molecular biomarkers and predictive models for tailored therapy is a crucial challenge and area of emphasis in medical research.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s) . The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.  \nThe FASEB Journal, 2026; 40:e71637 1 of","cbCaivnjgq78MXUB","https://ap.wps.com/l/cbCaivnjgq78MXUB","pdf",19506955,24,"English","# Introduction","[{\"question\":\"What cohorts and methods were used to construct the prognostic model for LGG?\",\"answer\":\"The study used TCGA and CGGA cohorts, applying consensus clustering based on lactate metabolism genes. A predictive model was built using differential analysis, Cox regression, and LASSO.\"},{\"question\":\"How does the three-gene signature relate to patient risk and immune features?\",\"answer\":\"The signature (VAV3, TNFRSF12A, PLA2G2A) distinguishes high-risk from low-risk patients with high predictive accuracy. High-risk patients show reduced immune infiltration and increased TMB, corresponding to worse prognosis.\"},{\"question\":\"How was the key gene PLA2G2A functionally validated?\",\"answer\":\"PLA2G2A expression and impact were assessed with RT-qPCR, Western blot, immunofluorescence, ELISA, CCK-8, Transwell assays, and mouse tumorigenesis experiments, showing that downregulation suppresses tumor progression and reverses EMT.\"}]","Lactate Metabolism-Immune Regulation-Related Gene Signature in Lower-Grade Gliomas - Prognostic Model Development and Immune Characterization | PDF",1790136143,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2bbe94a0d76dc288dbf4acfa06652dc9.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05beff507f43a7752428e7f7a0964226.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8200083b37e741deb90223007a877adf.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27560a06eb2226b8c442890d31bb65f9.webp",980,1287]